Cancer/Tumor Profiling Market Excellent Growth 2021 Top Key Players
Cancer profiling is a technique used to classify tumors more accurately, which helps in predicting the patient's clinical outcome. Cancer/Tumor profiling helps in identification of genomic alteration, which aid to choose a proper therapy for treating cancer. This technique reduces the trial and error process in diagnosis of cancer at various stages and provide more precise and accurate information about clinical outcomes of cancer. Different tests are utilized in the diagnosis of cancer such as for instance laboratory test (blood and urine), biopsy, imaging test (X-ray, MRI, PET/CT, and ultrasound), nuclear medicine scan, and lumber puncture, which is unable to identify exact reason for cancer in early stages. This is often resulted in over-treatment of cancer patients.
A number of the major key players operating in the global Cancer/Tumor Profiling Market include Proteome Sciences PLC, Life Technologies Corporation, Illumina, Inc., BioTheranostics, RiboMed Biotechnologies Inc., NeoGenomics Laboratories, Oxford Gene Technology Ltd., Genomic Health Inc., Agendia, and Oncopath Laboratories.
Furthermore, in accordance with Cancer Research UK, around 356,860 new cases of cancer were diagnosed in 2014, where most typical cancers were breast, prostate, and lung or bowel cancer. The data represent increasing incidence and prevalence of cancer globally which will be likely to function as the major driving factor for the cancer profiling market during the forecast period.
Comments
Post a Comment